Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits

Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits

This CE course will teach you the latest evidence and guidelines related to postmenopausal hormone therapy in treating menopausal symptoms, including its role in CVD risk reduction.

Credit:
0.75 Hour CE
Cost: Free

Take this Course

Faculty:

  • Cynthia Stuenkel, MD, NCMP

Upon completion of this program, participants will be able to: 

  • Describe an evidence-based approach to shared decision making for the clinician and perimenopausal patient considering menopausal hormone therapy or selective estrogen receptor modulators

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.